“This collaboration represents a meaningful step toward realizing the therapeutic potential of bispecific and trispecific ADCs,” said Roland Green, CEO of Invenra
October 22, 2025
“This collaboration represents a meaningful step toward realizing the therapeutic potential of bispecific and trispecific ADCs,” said Roland Green, CEO of Invenra